175 related articles for article (PubMed ID: 37990271)
1. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability.
Han L; Jiang Y; Shi M; Gan L; Wu Z; Xue M; Zhu Y; Xiong C; Wang T; Lin X; Shen B; Jiang L; Chen H
J Transl Med; 2023 Nov; 21(1):838. PubMed ID: 37990271
[TBL] [Abstract][Full Text] [Related]
2. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
3. Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis.
Hu LP; Zhang XX; Jiang SH; Tao LY; Li Q; Zhu LL; Yang MW; Huo YM; Jiang YS; Tian GA; Cao XY; Zhang YL; Yang Q; Yang XM; Wang YH; Li J; Xiao GG; Sun YW; Zhang ZG
Clin Cancer Res; 2019 Feb; 25(4):1318-1330. PubMed ID: 30420446
[TBL] [Abstract][Full Text] [Related]
4. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract][Full Text] [Related]
5. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
6. Glycolysis and tumor progression promoted by the m
Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
[TBL] [Abstract][Full Text] [Related]
7. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin U regulates the anti-tumor activity of CD8
Zheng R; Wang S; Wang J; Zhou M; Shi Q; Liu B
Cancer Sci; 2024 Feb; 115(2):334-346. PubMed ID: 38071753
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
10. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma.
Wang L; Wang F; Na L; Yu J; Huang L; Meng ZQ; Chen Z; Chen H; Ming LL; Hua YQ
Cancer Biomark; 2018; 22(1):169-174. PubMed ID: 29526843
[TBL] [Abstract][Full Text] [Related]
11. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
[TBL] [Abstract][Full Text] [Related]
12. IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.
Yang J; Liu DJ; Zheng JH; He RZ; Xu DP; Yang MW; Yao HF; Fu XL; Yang JY; Huo YM; Tao LY; Hua R; Sun YW; Kong XM; Jiang SH; Liu W
Cell Oncol (Dordr); 2022 Jun; 45(3):367-379. PubMed ID: 35486320
[TBL] [Abstract][Full Text] [Related]
13. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
14. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
Ju HQ; Zhuang ZN; Li H; Tian T; Lu YX; Fan XQ; Zhou HJ; Mo HY; Sheng H; Chiao PJ; Xu RH
Cancer Lett; 2016 Aug; 379(1):1-11. PubMed ID: 27233476
[TBL] [Abstract][Full Text] [Related]
16. Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis.
Guan H; Luo W; Liu Y; Li M
Cell Death Dis; 2021 Jun; 12(7):645. PubMed ID: 34168116
[TBL] [Abstract][Full Text] [Related]
17. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.
Chen PC; Ning Y; Li H; Su JG; Shen JB; Feng QC; Jiang SH; Shi PD; Guo RS
Cell Oncol (Dordr); 2024 Feb; 47(1):81-96. PubMed ID: 37606818
[TBL] [Abstract][Full Text] [Related]
18. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.
Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z
J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745
[TBL] [Abstract][Full Text] [Related]
19. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
[TBL] [Abstract][Full Text] [Related]
20. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
